Quick Answer
Health In Tech, Inc. reported Cash and Equivalents of $7.67 million for fiscal year 2025.
Health In Tech, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $7.67M | -2.3% |
| 2024 | $7.85M | +224.8% |
| 2023 | $2.42M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $8.02M | — | -1.4% |
| June 30, 2025 | $8.14M | — | +7.4% |
| March 31, 2025 | $7.58M | — | -3.5% |
| December 31, 2024 | $7.85M | — | — |
- Health In Tech, Inc. showed a decrease of -2.3% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2023–2025 period, Health In Tech, Inc.’s cash and equivalents has grown by 217.4% (from $2.42 million to $7.67 million).
- The most recent figure is from Health In Tech, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: